手机购彩

Heavy! Hengrui Pharmaceutical Class 1 New Drug Remazolam Tosylate for Injection Approved
Recently, Hengrui Medicine received the Drug Registration Approval issued by the State Drug Administration, approving the company's Class 1 innovative drug Remazolam Toluenesulfonate for injection (brand name: Rebinin). Remazolol tosylate for injection belongs to benzodiazepines, and it is a new type of short-acting GABAa receptor agonist. It is metabolized by systemic plasma esterase, and the metabolites are inactive and have fast onset of action ...
2020-01-02
Promoting Stability and Promoting Innovation——Hengrui Medicine's New Year Message in 2020
The age will change, and the day will be new. We are about to bid farewell to the extraordinary 2019 and move towards a new journey 2020 full of opportunities and challenges. At this moment of resignation, I would like to represent the company's management team to the employees and their families who work hard on all fronts and positions, and express my sincere gratitude to the leaders and friends from all walks of life who have cared, supported and helped the company for a long time And sincere wishes!
2019-12-31
Hengrui Medicine: 2019 moves forward with change, dreams illuminate the distance
The order is easy, and Hua Zhang is new. Inadvertently, 2019 is about to leave us, and 2020 is striding towards us. This year was a landmark year for the great motherland. The 70th National Day celebrates the nation. This year, for Hengrui people, it was a year of advancing through the changes and meeting the difficulties. Hundreds of people struggling to flow, bravely set the tide, the hard-working Hengrui people stood more upright in the storm. ...
2019-12-31
Hengrui Medicine Class 1 New Drug Flurazole Pali Capsule Was Included in Priority Review
Recently, Hengrui Pharmaceutical's new class 1 drug, fluzopalyl capsules, as an innovative drug with obvious therapeutic advantages, has been included in the publicity list of priority varieties for review by the Drug Evaluation Center of the State Drug Administration. Fluroxaparil is a poly (ADP-ribose) polymerase (PARP) inhibitor, which can specifically kill BRCA-mutated tumor cells, and is used to treat past second-line and above ...
2019-12-09
New drugs approved by Hengrui Medicine for breast cancer and lung cancer
Recently, Hengrui Medicine received the "Clinical Trial Notification" for the company's pirlotinib tablets, SHR6390, and SHR-1316 injections approved by the State Drug Administration and approved the combination of pirlotinib maleate tablets A randomized, double-blind, parallel-controlled, totuzumab plus docetaxel versus placebo combined with trastuzumab plus docetaxel for early or locally advanced HER2-positive breast cancer before surgery ...
2019-12-07
Heavy! Hengrui Pharmaceutical Celecoxib Capsule Approved for the First Time
Recently, Hengrui Medicine received the Drug Registration Approval issued by the State Drug Administration and approved the company's Celecoxib capsules for sale. Celecoxib is a non-steroidal anti-inflammatory drug that selectively inhibits COX-2. It is mainly used to relieve the symptoms and signs of osteoarthritis, adult rheumatoid arthritis and ankylosing spondylitis, and to treat acute pain in adults. The original drug was approved by the US FDA in 1998 ...
2019-12-06
Heavy! Hengrui Medicine Pirlotinib Maleate Tablets and Thiperifilastine Injected into National Medical Insurance Directory
Today (November 28), the National Medical Security Administration, the Ministry of Human Resources and Social Security announced the full version of the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalogue" in 2019, and pyrrole maleate independently developed by Hengrui Medicine Tinib tablets and thiopefilgrastim injection were successfully negotiated and included in the national health insurance catalog
2019-11-28
Hengrui Medicine Esketamine Hydrochloride Injection Approved for the First Time in China
Recently, Hengrui Medicine received the Drug Registration Approval issued by the State Drug Administration and approved the company's esketamine hydrochloride injection for sale.
2019-11-28
上一页 1 2 3 4 ... 11 下一页 Total 86 recordsPrevious page 1 2 3 4 ... 11Next page